Methods and Compositions for the Prevention and Treatment Neuropathy
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/US2013/034647, filed Mar 29, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,279,008 | Methods and Compositions for Increasing the Dose of a Chemotherapeutic Agent In force · High confidence UsedRemaining | Stealth Biotherapeutics Inc. | In force | High confidence | ||
| US 10,646,539 | Methods and Compositions for the Treatment of Neuropathy and Hyperalgesia In force · High confidence | Stealth Biotherapeutics Inc. | In force | High confidence | ||
| US 11,998,585 | Methods and Compositions for Increasing the Dose of a Chemotherapeutic Agent In force · High confidence | Stealth Biotherapeutics Inc. | In force | High confidence | ||
| US 9,636,378 | Methods and Compositions for the Prevention and Treatment Neuropathy In force · High confidence | Stealth Biotherapeutics Inc. | In force | High confidence | ||
| Application 16/842,040 | Methods and Compositions for the Prevention and Treatment Neuropathy Abandoned Abandoned Mar 10, 2022 | Stealth Biotherapeutics Inc. | Abandoned | Abandoned Mar 10, 2022 |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Stealth Biotherapeutics Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.